Chison Medical Technologies Co Ltd
Chison Medical Technologies Co., Ltd. develops, manufactures, and sells diagnostic ultrasound systems in China and internationally. Its products include cart-based, portable, handheld, and B&W ultrasound systems. The company was founded in 1996 and is based in Wuxi, China.
Chison Medical Technologies Co Ltd (688358) - Net Assets
Latest net assets as of September 2025: CN¥1.40 Billion CNY
Based on the latest financial reports, Chison Medical Technologies Co Ltd (688358) has net assets worth CN¥1.40 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.58 Billion) and total liabilities (CN¥177.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.40 Billion |
| % of Total Assets | 88.76% |
| Annual Growth Rate | 44.12% |
| 5-Year Change | 19.09% |
| 10-Year Change | N/A |
| Growth Volatility | 147.62 |
Chison Medical Technologies Co Ltd - Net Assets Trend (2016–2024)
This chart illustrates how Chison Medical Technologies Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Chison Medical Technologies Co Ltd (2016–2024)
The table below shows the annual net assets of Chison Medical Technologies Co Ltd from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.42 Billion | +3.76% |
| 2023-12-31 | CN¥1.37 Billion | +4.23% |
| 2022-12-31 | CN¥1.31 Billion | +5.45% |
| 2021-12-31 | CN¥1.25 Billion | +4.42% |
| 2020-12-31 | CN¥1.19 Billion | +1.89% |
| 2019-12-31 | CN¥1.17 Billion | +459.73% |
| 2018-12-31 | CN¥209.17 Million | +45.08% |
| 2017-12-31 | CN¥144.18 Million | +88.91% |
| 2016-12-31 | CN¥76.32 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Chison Medical Technologies Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 8742.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥356.98 Million | 25.13% |
| Common Stock | CN¥112.12 Million | 7.89% |
| Other Components | CN¥951.48 Million | 66.98% |
| Total Equity | CN¥1.42 Billion | 100.00% |
Chison Medical Technologies Co Ltd Competitors by Market Cap
The table below lists competitors of Chison Medical Technologies Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Symphony Limited
NSE:SYMPHONY
|
$128.85 Million |
|
Shanghai Lianming Machinery Co Ltd
SHG:603006
|
$128.88 Million |
|
SELVITA S.A. SER.B ZY-80
F:787
|
$128.95 Million |
|
NEX POINT
BK:NEX-R
|
$128.99 Million |
|
Eagle Financial Services Inc Common Stock
OTCQX:EFSI
|
$128.78 Million |
|
Sedlmayr Grund und Immobilien AG
F:SPB
|
$128.77 Million |
|
Pacific Hospital Supply Co Ltd
TWO:4126
|
$128.74 Million |
|
BASSAC EO 1
F:78Y
|
$128.73 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Chison Medical Technologies Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,369,068,613 to 1,420,586,554, a change of 51,517,941 (3.8%).
- Net income of 140,505,142 contributed positively to equity growth.
- Dividend payments of 89,499,802 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥140.51 Million | +9.89% |
| Dividends Paid | CN¥89.50 Million | -6.3% |
| Other Changes | CN¥512.60K | +0.04% |
| Total Change | CN¥- | 3.76% |
Book Value vs Market Value Analysis
This analysis compares Chison Medical Technologies Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.49x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 34.74x to 2.49x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CN¥0.91 | CN¥31.70 | x |
| 2017-12-31 | CN¥1.72 | CN¥31.70 | x |
| 2018-12-31 | CN¥2.48 | CN¥31.70 | x |
| 2019-12-31 | CN¥10.45 | CN¥31.70 | x |
| 2020-12-31 | CN¥10.65 | CN¥31.70 | x |
| 2021-12-31 | CN¥11.12 | CN¥31.70 | x |
| 2022-12-31 | CN¥11.71 | CN¥31.70 | x |
| 2023-12-31 | CN¥12.43 | CN¥31.70 | x |
| 2024-12-31 | CN¥12.74 | CN¥31.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Chison Medical Technologies Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.89%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 29.98%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.12x
- Recent ROE (9.89%) is below the historical average (20.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 39.92% | 18.25% | 1.09x | 2.01x | CN¥22.83 Million |
| 2017 | 44.42% | 23.58% | 1.14x | 1.65x | CN¥49.63 Million |
| 2018 | 45.45% | 29.07% | 1.01x | 1.55x | CN¥74.15 Million |
| 2019 | 8.98% | 28.43% | 0.29x | 1.10x | CN¥-11.95 Million |
| 2020 | 8.35% | 29.91% | 0.25x | 1.13x | CN¥-19.65 Million |
| 2021 | 9.03% | 28.27% | 0.28x | 1.12x | CN¥-12.09 Million |
| 2022 | 8.06% | 27.79% | 0.25x | 1.15x | CN¥-25.51 Million |
| 2023 | 10.70% | 30.27% | 0.32x | 1.11x | CN¥9.57 Million |
| 2024 | 9.89% | 29.98% | 0.29x | 1.12x | CN¥-1.55 Million |
Industry Comparison
This section compares Chison Medical Technologies Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Chison Medical Technologies Co Ltd (688358) | CN¥1.40 Billion | 39.92% | 0.13x | $128.78 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |